These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice. Kozakowska M; Kotlinowski J; Grochot-Przeczek A; Ciesla M; Pilecki B; Derlacz R; Dulak J; Jozkowicz A Stem Cell Res Ther; 2015 Apr; 6(1):61. PubMed ID: 25889676 [TBL] [Abstract][Full Text] [Related]
24. Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts. Wang X; Wu H; Zhang Z; Liu S; Yang J; Chen X; Fan M; Wang X Cell Mol Neurobiol; 2008 Jan; 28(1):113-24. PubMed ID: 18240017 [TBL] [Abstract][Full Text] [Related]
25. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death. Gancz D; Donin N; Fishelson Z Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026 [TBL] [Abstract][Full Text] [Related]
26. Mutational status of the p53 gene modulates the basal level of jun N-terminal kinase and its inducibility by ultraviolet irradiation in A1-5 rat fibroblasts. Ramaswamy NT; Pelling JC Mol Carcinog; 1999 Aug; 25(4):262-72. PubMed ID: 10449033 [TBL] [Abstract][Full Text] [Related]
27. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270 [TBL] [Abstract][Full Text] [Related]
28. CaMKK2 Suppresses Muscle Regeneration through the Inhibition of Myoblast Proliferation and Differentiation. Ye C; Zhang D; Zhao L; Li Y; Yao X; Wang H; Zhang S; Liu W; Cao H; Yu S; Wang Y; Jiang J; Wang H; Li X; Ying H Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783047 [TBL] [Abstract][Full Text] [Related]
29. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. Varona-Santos JL; Pileggi A; Molano RD; Sanabria NY; Ijaz A; Atsushi M; Ichii H; Pastori RL; Inverardi L; Ricordi C; Fornoni A Diabetologia; 2008 Dec; 51(12):2271-80. PubMed ID: 18853132 [TBL] [Abstract][Full Text] [Related]
30. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice. Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962 [TBL] [Abstract][Full Text] [Related]
31. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle. White JD; Davies M; Grounds MD Cell Tissue Res; 2001 Oct; 306(1):129-41. PubMed ID: 11683174 [TBL] [Abstract][Full Text] [Related]
32. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia. Seto DN; Kandarian SC; Jackman RW J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726 [TBL] [Abstract][Full Text] [Related]
33. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Zhong S; Fromm J; Johnson DL Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809 [TBL] [Abstract][Full Text] [Related]
34. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216 [TBL] [Abstract][Full Text] [Related]
35. LIF is a contraction-induced myokine stimulating human myocyte proliferation. Broholm C; Laye MJ; Brandt C; Vadalasetty R; Pilegaard H; Pedersen BK; Scheele C J Appl Physiol (1985); 2011 Jul; 111(1):251-9. PubMed ID: 21527666 [TBL] [Abstract][Full Text] [Related]
36. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. Coffey ET; Smiciene G; Hongisto V; Cao J; Brecht S; Herdegen T; Courtney MJ J Neurosci; 2002 Jun; 22(11):4335-45. PubMed ID: 12040039 [TBL] [Abstract][Full Text] [Related]
37. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188 [TBL] [Abstract][Full Text] [Related]
38. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. Jones NC; Fedorov YV; Rosenthal RS; Olwin BB J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804 [TBL] [Abstract][Full Text] [Related]
39. S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis. Tubaro C; Arcuri C; Giambanco I; Donato R Biochim Biophys Acta; 2011 May; 1813(5):1092-104. PubMed ID: 21130124 [TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α. Ono Y; Sakamoto K PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]